Lan-Feng Tsai

MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study

Phil Ambery, Victoria E R Parker, Michael Stümvoll et al. · The Lancet · 2018 · 295 citations

Medicine, Endocrinology, Pharmacology +15

Effects of aripiprazole once-monthly on domains of personal and social performance: Results from 2 multicenter, randomized, double-blind studies

W. Wolfgang Fleischhacker, Ross A. Baker, Anna Eramo et al. · Schizophrenia Research · 2014 · 26 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial

John E. Le Lay, Qun Du, Minal B. Mehta et al. · Science Translational Medicine · 2021 · 24 citations

Life Sciences, Biochemistry, Pharmacology +17

Patient-Centered Outcomes with Aripiprazole Once-Monthly for Maintenance Treatment in Patients with Schizophrenia: Results From Two Multicenter, Randomized, Double-Blind Studies

John M. Kane, Raymond Sanchez, Ross A. Baker et al. · Clinical Schizophrenia & Related Psychoses · 2015 · 17 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis

Anna Eramo, Wally Landsberg, Dušan Kostic et al. · Neuropsychiatric Disease and Treatment · 2015 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17